New Deal Video Launch – New nanotherapy research for inflammatory bowel diseases

New DealNew DealLeave a Comment

Over two million people in Europe live with an inflammatory bowel disease (IBD). Besides, the number of patients is increasing and it’s become one of the most common immune-mediated diseases in young adults. Among the IBDs, Crohn’s disease and ulcerative colitis, are the most common. The current treatments include drugs and biological therapy. But, their efficacy is low and both … Read More

NEW DEAL was rewarded at Mayoly’s Forum

PaulineInflammatory bowel diseases, Nanotherapy, New Deal

The Mayoly Management Forum took place from the 5th to the 8th of February, in Valence. The event gathered all the managers from Mayoly and at this occasion the New Deal project was presented. A new nanotherapy research for inflammatory bowel diseases The goal of the project NEW DEAL is to design and validate a new targeted therapy against inflammatory bowel diseases (IBDs). This … Read More

13th Congress of European Crohn’s and Colitis Organisation


So far, ECCO has organised twelve congresses attracting a very large number of attendees with expertise in Inflammatory Bowel Diseases. Although most come from Europe, a considerable number come from North and South America, the Gulf States, the Far East, Australia and New Zealand. The last congress, organised in Barcelona in February 2017, attracted a number of 6,249 participants (incl. exhibitors) from 84 … Read More